The Latest Cardiac and Vascular News
IRVINE, Calif., July 24, 2023 /PRNewswire/ — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small electrodes arranged in a fixed […]
SCOTTSDALE, Ariz., June 28, 2019 /PRNewswire-PRWeb/ — Innovative Health, the leading single-use cardiology medical device reprocessing company, today announced it has received FDA clearance for reprocessing the market-leading PENTARAY® Nav eco High-Density mapping catheter (hereinafter PentaRay), a development that represents both a technological and healthcare cost reduction milestone. The PentaRay is a key medical device in Atrial Fibrillation […]
Researchers Report QDOT MICRO Radiofrequency Ablation Catheter Demonstrates Safety and Achieves Pulmonary Vein Isolation with Shorter Procedure and Fluoroscopy Times SAN FRANCISCO — May 9, 2019 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency (RF) ablation, demonstrated safety and […]
San Francisco– May 7, 2019 – Johnson & Johnson Medical Devices Companies* today announced the launch of Biosense Webster, Inc.’s CARTONET as part of the company’s mission to help revolutionize the way electrophysiologists, hospitals, health systems, and researchers leverage and share data with the goal of improving patient outcomes and operational efficiency in catheter ablation […]
IRVINE, Calif., Feb. 4, 2019 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study** which evaluates the company’s QDOT MICRO Radiofrequency (RF) Ablation Catheter used for […]
IRVINE, Calif., May 2, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its QDOT AF Study.** The study will evaluate the delivery of high power, short duration ablation with QDOT MICRO, a novel […]
